We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SWTX market cap is 2.56B. The company's latest EPS is USD -4.3771 and P/E is -7.90.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 5.45M | 21.01M | 59.73M |
| Operating Income | -83.75M | -85.02M | -100.3M | -94.96M | -46.7M |
| Net Income | -77.93M | -79.44M | -94.32M | -87.39M | -39.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 35M | 0 | 0 | 5.45M |
| Operating Income | -61.85M | -46.93M | -174.46M | -283.56M | -348.05M |
| Net Income | -50.58M | -45.57M | -173.91M | -277.42M | -325.1M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 517.33M | 467.65M | 725.79M | 656.83M | 617.33M |
| Total Liabilities | 65.89M | 72.76M | 99.57M | 89.39M | 60.6M |
| Total Equity | 451.44M | 394.9M | 626.22M | 567.44M | 556.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 334.83M | 576.19M | 452.49M | 630.24M | 725.79M |
| Total Liabilities | 12.76M | 19.13M | 30.1M | 72.05M | 99.57M |
| Total Equity | 322.07M | 557.06M | 422.4M | 558.19M | 626.22M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -109.63M | -160.09M | -222.8M | -78.93M | -120.72M |
| Investing | 159.36M | 193.96M | 34.75M | 21.46M | 21.75M |
| Financing | -2.19M | -2.43M | 296.64M | -552k | 2.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -47.44M | -32.19M | -127.88M | -161.56M | -222.8M |
| Investing | -4.26M | -418.83M | 83.59M | -215.6M | 34.75M |
| Financing | 333.71M | 270.49M | 1.16M | 340.7M | 296.64M |
| Market Cap | 2.56B |
| Price to Earnings Ratio | -7.90 |
| Price to Sales Ratio | 471.9 |
| Price to Cash Ratio | 14.59 |
| Price to Book Ratio | 4.1 |
| Dividend Yield | - |
| Shares Outstanding | 74.27M |
| Average Volume (1 week) | 2.83M |
| Average Volume (1 Month) | 1.31M |
| 52 Week Change | 60.01% |
| 52 Week High | 53.92 |
| 52 Week Low | 20.1919 |
| Spread (Intraday) | 0.4 (1.15%) |
| Company Name | SpringWorks Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.springworkstx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
